利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.019 秒)

    Surface protection coating for glass sheets
    1.
    发明申请
    Surface protection coating for glass sheets 审中-公开
    玻璃板表面保护涂层

    公开(公告)号：US20050053768A1

    公开(公告)日：2005-03-10

    申请号：US10656686

    申请日：2003-09-04

    申请人： Thomas Friedman ,  Hongkyu Kim ,  Teresa Nolet

    发明人： Thomas Friedman ,  Hongkyu Kim ,  Teresa Nolet

    IPC分类号： B32B3/30 ,  B32B17/06 ,  B32B17/10 ,  B65D85/48 ,  B65G49/06 ,  C03C17/32 ,  C03C17/42

    CPC分类号： B32B17/06 ,  B32B3/30 ,  B32B17/10018 ,  B32B17/10577 ,  B32B2439/00 ,  B65D85/48 ,  B65G49/069 ,  C03C17/328 ,  C03C17/42 ,  C03C2204/08 ,  C03C2218/355 ,  Y10T428/2457 ,  Y10T428/31616 ,  Y10T428/31649

    摘要： A method is described herein for packaging a plurality of glass sheets by: (1) coating a top surface of each glass sheet with a removable top protective film; (2) coating a bottom surface of each glass sheet with a removable bottom protective film; and (3) stacking the coated glass sheets next to one another such that the top protective film of one glass sheet is adjacent to the bottom protective film of another glass sheet. The top protective film and/or bottom protective film on each glass sheet has embossed features (e.g., rough features) formed therein which make it easier to separate one glass sheet from one another glass sheet because of the presence of air pockets caused by the embossed features located between the stacked glass sheets. The coated glass sheet and a container that can store a plurality of the coated glass sheets are also described herein.

    摘要翻译： 本文描述了通过以下步骤包装多个玻璃板的方法：（1）用可移除的顶部保护膜涂覆每个玻璃板的顶表面; （2）用可移除的底部保护膜涂覆每个玻璃板的底面; 和（3）将涂覆的玻璃板彼此叠放，使得一块玻璃板的顶部保护膜与另一块玻璃板的底部保护膜相邻。 每个玻璃板上的顶部保护膜和/或底部保护膜具有形成在其中的压花特征（例如，粗糙的特征），这使得更容易将一个玻璃板与另一个玻璃板分开，因为存在由压花引起的气泡 特征位于堆叠的玻璃板之间。 本文还描述了涂覆的玻璃板和可以储存多个涂覆的玻璃板的容器。

    Transductin-1 and transductin-2 and applications to hereditary deafness
    2.
    发明申请
    Transductin-1 and transductin-2 and applications to hereditary deafness 失效
    Transductin-1和转导素-2以及遗传性耳聋的应用

    公开(公告)号：US20050196759A1

    公开(公告)日：2005-09-08

    申请号：US10792307

    申请日：2004-03-03

    申请人： Andrew Griffith ,  Kiyoto Kurima ,  Edward Wilcox ,  Thomas Friedman

    发明人： Andrew Griffith ,  Kiyoto Kurima ,  Edward Wilcox ,  Thomas Friedman

    IPC分类号： C07H21/04 ,  C07K14/705 ,  C07K16/28 ,  C12N15/09 ,  C12Q1/68

    CPC分类号： C12Q1/6883 ,  C07K14/705 ,  C12Q2600/156

    摘要： The invention provides an isolated or purified nucleic acid molecule consisting essentially of the nucleotide sequence encoding transductin-2 (TDC2), related and derivative nucleic acid molecules, vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.

    摘要翻译： 本发明提供了分离或纯化的核酸分子，其基本上由编码转氨酶-2（TDC2），相关和衍生的核酸分子的核苷酸序列组成，包含分离或纯化的核酸序列的载体，包含此类载体的细胞，由 核酸分子，单克隆抗体和产生单克隆抗体的细胞系。 本发明还提供治疗，预后和监测听力损失的方法。

    TRANSDUCTIN-1 AND TRANSDUCTIN-2 AND APPLICATIONS TO HEREDITARY DEAFNESS
    6.
    发明申请
    TRANSDUCTIN-1 AND TRANSDUCTIN-2 AND APPLICATIONS TO HEREDITARY DEAFNESS 有权
    转录因子-1和转录因子2和应用于放射治疗

    公开(公告)号：US20070099271A1

    公开(公告)日：2007-05-03

    申请号：US11615250

    申请日：2006-12-22

    申请人： Andrew Griffith ,  Kiyoto Kurima ,  Edward Wilcox ,  Thomas Friedman

    发明人： Andrew Griffith ,  Kiyoto Kurima ,  Edward Wilcox ,  Thomas Friedman

    IPC分类号： A61K48/00 ,  C07K14/705 ,  C07H21/04 ,  C12P21/06

    CPC分类号： C12Q1/6883 ,  A61K38/00 ,  C07K14/705 ,  C12Q2600/156 ,  C12Q2600/158

    摘要： The invention provides an isolated or purified nucleic acid molecules consisting essentially of the nucleotide sequence encoding either transductin-1 (TDC1) or transductin-2 (TDC2), related and derivative nucleic acid molecules vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.

    摘要翻译： 本发明提供了分离或纯化的核酸分子，其基本上由编码转氨酶-1（TDC1）或转座蛋白-2（TDC2）的核苷酸序列组成，包含分离或纯化的核酸序列的相关和衍生的核酸分子载体，包含 这样的载体，由核酸分子编码的多肽，单克隆抗体和产生单克隆抗体的细胞系。 本发明还提供治疗，预后和监测听力损失的方法。